Article Details

Theravance Biopharma, Inc. Announces Top-Line Results From Phase 2 Study of Nezulcitinib In ...

Retrieved on: 2021-06-21 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma, Inc. Announces Top-Line Results From Phase 2 Study of Nezulcitinib In .... View article details on HISWAI: https://baytownsun.com/coronavirus/article_641178ba-d001-5017-a100-ec7fd2fd4a4e.html

Excerpt

("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, ...

Article found on: baytownsun.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up